High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study

Clinical trial NCT00589953 · TERMINATED

Trial details

NCT number: NCT00589953
Sponsor: Atlantic Health System
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Infant, Premature Erythropoietin Brain Injury Intraventricular Hemorrhage Periventricular Leukomalacia Neurodevelopmental Outcomes Randomized Clinical Trial

Start date: 2007-07-01
Primary completion: 2010-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.